Philip Berardi

Dr. Berardi is Section Head of complex Malignant Hematopathology at the Ottawa Hospital, and Associate Professor of Pathology in the Faculty of Medicine at the University of Ottawa. He is the current chair of the Hematopathology Interest Group within the Canadian Leukemia Study Group (CLSG) and executive within the Canadian Association of Pathologists (CAP-ACP) Section on Hematopathology.

His research interests include diagnostic and prognostic markers in non-Hodgkin lymphoma, acute leukemia and plasma cell disorders, and molecular diagnosis of leukemia and lymphoma. He participates in numerous multi-institutional research efforts including active collaborations with the Ontario Molecular Pathology Research Network (OMPRN) and the Ontario Institute for Cancer Research (OICR). Dr. Berardi is a regular contributor to guidelines issued through the Cancer Care Ontario (CCO) – Program in Evidence-Based Care (PEBC).